Healthcare insights through
cost-effectiveness research
What you see is what you get.
Huygens & Versteegh is a company for health economic research. It’s just the two of us. We don’t outsource, we sit down with you ourselves to answer your questions with cost-effectiveness analyses.
Trust in numbers.
Numbers rarely reflect the complex societal sensitivities regarding healthcare but they do provide insights in the efficiency and equity of healthcare interventions. We generate results that people can trust by carefully building health economic models that reflect clinical reality and involve all stakeholders.
Simone and Matthijs.
-
Simone Huygens, PhD
Simone is a health economic researcher with a strong clinical and methodological background. She has specialized in the field of heart valve replacements and multiple sclerosis, but can quickly get acquainted with other medical conditions. Due to her experience with early cost-effectiveness analyses she can generate meaningful results in any stage of the product development. Moreover, she will make sure your project is executed carefully and within the agreed timelines. Her main interests are health economic modelling in R and providing insights in data through visualisation of results.
-
Matthijs Versteegh, PhD
Matthijs is a health economic researcher with a large track record on advising governments, listed companies and start ups. He is a former director of the institute for Medical Technology Assessment, a member of the EuroQoL research foundation and an editorial board member of Medical Decision Making. He has the ability to translate complex technical matters in simple language for everyone to understand. His main interests are health economic modelling in R, and quality of life measurement and valuation for use in cost-effectiveness analysis.
Scientific track record.
Our work is published in well known peer reviewed scientific journals in the field of health technology assessment and health economics, such as Value in Health, Health Economics and Pharmacoeconomics.
Featured publications.
Our services.
-
Cost-effectiveness analysis
We conduct high quality cost-effectiveness analyses in the statistical software ‘R’ to estimate the value for money of healthcare interventions.
-
Disease model
We develop disease models incorporating the patient’s entire lifetime including treatment switches that can estimate the cost-effectiveness of treatment sequences instead of single treatments.
-
Multiple sclerosis
Cost-effectiveness analyses in the field of MS with the iMTA/ErasmusMC MS model as published by Huygens & Versteegh (2021).